Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 883, doi. 10.1038/cgt.2009.33
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 12
Results: 7
1
2
Anticancer oncolytic activity of respiratory syncytial virus.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 923, doi. 10.1038/cgt.2009.34
- By:
- Publication type:
- Article
3
WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 892, doi. 10.1038/cgt.2009.35
- By:
- Publication type:
- Article
4
New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 912, doi. 10.1038/cgt.2009.36
- By:
- Publication type:
- Article
5
Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 900, doi. 10.1038/cgt.2009.39
- By:
- Publication type:
- Article
6
Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 12, p. 873, doi. 10.1038/cgt.2009.40
- By:
- Publication type:
- Article
7
Anticancer oncolytic activity of respiratory syncytial virus.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice